Your institution may have access to this item. Find your institution then sign in to continue.
Title
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
Authors
De Rycke, L; Verhelst, X; Kruithof, E; Van den Bosch, F; Hoffman, I E A; Veys, E M; De Keyser, F
Abstract
To analyse the effect of infliximab on IgM rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibodies, and determine whether baseline autoantibody titres (IgM RF and anti-CCP antibodies) are associated with changes in acute phase reactants.
Publication
Annals of the rheumatic diseases, 2005, Vol 64, Issue 2, p299